Geron (GERN) EBITDA Margin (QoQ) (2010 - 2026)
Geron (GERN) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Geron | 1.05 Mn | -299.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,204.00 |
| Mar 31, 2026 | -1,904.00 |
| Dec 31, 2025 | 4,875.00 |
| Sep 30, 2025 | -401.00 |
| Jun 30, 2025 | 1,678.00 |
| Mar 31, 2025 | -11,142.00 |
| Dec 31, 2024 | 16,904.00 |
| Sep 30, 2024 | 776,108.00 |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | -4.38 Mn |
| Dec 31, 2023 | 5.44 Mn |
| Sep 30, 2023 | 15.01 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | -15.02 Mn |
| Dec 31, 2022 | -2.73 Mn |
| Sep 30, 2022 | 2.49 Mn |
| Jun 30, 2022 | -1.50 Mn |
| Mar 31, 2022 | -2.03 Mn |
| Dec 31, 2021 | 2.06 Mn |
| Sep 30, 2021 | 344,494.00 |